10 results
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Medications for Tobacco Cessation ... Smoking #Tobacco #Cessation ... #Therapy #Comparison ... #Table #Agents ... #Dosing
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
#Pharmacology #Comparison ... Table #HalfLife #Dosing ... Loop #Thiazide #CHF ... #Cardiology #Management
Pharmacotherapy for Smoking Cessation - Table of Short and Long-Acting Agents:

Long Acting: Nicotine Patch, Buproprion, Varenicline
Short
Pharmacotherapy for Smoking Cessation ... and Long-Acting Agents ... #Therapy #Comparison ... #Table #Agents ... #Dosing
Flowchart to diuretic use in acute heart failure.

(A) Congestion with volume overload. 

(B) Treatment algorithm after
(B) Treatment algorithm ... administration, once a day dosing ... Diuretic #Diuresis #CHF ... #Algorithm #Congestive ... #HeartFailure #Cardiology
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
STAGES of CHF (A ... mechanical pump that augments ... #Management #Cardiology ... #CHF #Congestive ... Stages #ACCAHA #Algorithm
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
nodal blocking agents ... pulmonary disease or CHF ... pulmonary disease or CHF ... Treatment #management #cardiology ... #algorithm
Myocarditis 

5 Principles of
Myocarditis:
1. Build clinical suspicion
2. Decide on EMBx
3. Manage acute cardiac injury
4. Manage chronic
Fulminant: - Acute HF ... Checkpoint Inhibitors: cessation ... precipitating agent ... diagnosis #management #cardiology
Stage I - Redistribution
In a normal chest film with the patient standing erect, the pulmonary vessels
In these cases comparison ... condition (left) and during ... a period of CHF ... #Clinical #Radiology ... #CXR #CHF #Cephalization
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... disease b) CHF ... event, follow ACC algorithm ... one post op Cardiology ... postoperative cardiac events
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
HER2 agents cause ... attributed to HER2 agents ... reversible with cessation ... every 3 months during ... Cardiotoxicity #cardiology